Aprea Therapeutics
APRE
#10751
Rank
โ‚ฌ7.14 M
Marketcap
0,58ย โ‚ฌ
Share price
1.23%
Change (1 day)
-67.33%
Change (1 year)

EPS for Aprea Therapeutics (APRE)

EPS in 2026 (TTM): -1,31ย โ‚ฌ

According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is -1,35ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,73ย โ‚ฌ an increase over its 2024 EPS that were of -2,08ย โ‚ฌ.

EPS history for Aprea Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,31ย โ‚ฌ-24.19%
2025-1,73ย โ‚ฌ-16.81%
2024-2,08ย โ‚ฌ
2022-85,01ย โ‚ฌ177.74%
2021-30,61ย โ‚ฌ-31.1%
2020-44,42ย โ‚ฌ70.91%
2019-25,99ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amedisys
AMED
2,28ย โ‚ฌ-269.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
0,84ย โ‚ฌ-162.34%๐Ÿ‡บ๐Ÿ‡ธ USA